Document Type
Presentation
Loading...
Publication Date
5-13-2021
Abstract
Health economics and outcomes research (HEOR) is a growing field that provides important information for making healthcare coverage and access decisions. As a scientific discipline that quantifies the economic, humanistic and clinical outcomes of medical technology, HEOR helps pharmaceutical and device manufacturers communicate the value of their innovations to stakeholders.
In this webinar, we explore relevant, updated content about the intersection between HEOR and Medical Affairs with Dr. Ahmad B. Naim, MD, Vice President, US Medical Affairs, Incyte Corporation. The need to demonstrate the value of products to multiple stakeholders in a dynamic healthcare landscape has driven an increasing intersection between traditional HEOR and Medical Affairs functions in order to generate strategic evidence and value communication throughout the product lifecycle.
Presentation: 59:30
Recommended Citation
Naim, MD, Ahmad B. and Maio, PharmD, MS, MSPH, Vittorio, "The Role of Medical Affairs in Health Outcomes Data Generation and Communication" (2021). Population Health Leadership Series: PopTalk Webinars. Paper 34.
https://jdc.jefferson.edu/phlspoptalk/34
Language
English
Comments
Presenter:
Ahmad B. Naim, MD
Vice President, US Medical Affairs
Incyte Corp
Dr. Naim is currently the Vice President of US Medical Affairs, Inflammation and Autoimmunity (IAI) at Incyte Corporation in Wilmington, DE. His work focuses on researching novel and innovative mechanism of actions and therapeutic options in immune-mediated inflammatory disorders of the skin and other organ systems, including atopic dermatitis and vitiligo. He leads a team of medical and scientific professionals that are committed to bringing these new effective and safe therapeutic options to patients in need.
Ahmad is an immunologist and medial specialist by training. He also possesses a rich and diverse background in clinical and translational medicine, molecular biology and genetics, and health economics and outcomes research. During his academic career, he researched the tumor necrosis factor (TNF) pathways as targets for various autoimmune conditions, p53, and SNIPs for immune-mediated hematologic malignancies.
Ahmad transitioned to an industry career over 15 years ago and has held various strategic and leadership positions in medical affairs, HEOR, and clinical development at Johnson and Johnson and at Incyte with increasing responsibilities. He has also held various leadership roles in clinical practice management, performance improvement, community medicine, and public health. He also holds an adjunct faculty position at Temple University’s School of Pharmacy in Philadelphia, PA, where he teaches at the graduate level. Previously, he was on the faculty at Thomas Jefferson University, and University of Pennsylvania in Philadelphia, PA.
Moderator:
Vittorio Maio, PharmD, MS, MSPH
Program Director, Applied Health Economics & Outcomes Research
Director, Health Economics & Outcomes Research Fellowship
Jefferson College of Population Health
Dr. Vittorio Maio has several roles at Thomas Jefferson University. A Research Professor, he is the Director of JCPH’s Applied Health Economics & Outcomes Research Program and the Director of our HEOR Fellowship Program. In addition, Vittorio is the Managing Director of the Center for Research in Medical Education and Health Care at Sidney Kimmel Medical College.
Dr. Maio is Associate Editor of the American Journal of Medical Quality, and serves as a reviewer for several professional journals, including JAMA-Internal Medicine, The Lancet, Pharmacoepidemiology & Drug Safety, Age and Aging and Drugs & Aging.
He also teaches and conducts research in his native Italy. Having received his Doctor of Pharmacy degree from the University of Perugia (Italy), Dr. Maio received Italian Pharmacist Board Certification and serves as a grant reviewer for the Italian Ministry of Health. He lectures on health policy issues at the University of Pisa, Italy and lectures on health services.